Banoxantrone dihydrochloride
Chemical Name: 1,4-Bis[[2-(dimethyloxidoamino)ethyl]amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride
Purity: ≥98%
Biological Activity
Banoxantrone dihydrochloride is a bioreductive prodrug; activated by hypoxia to yield the topoisomerase II inhibitor AQ4. Displays little to no cytotoxic activity against 60 tumor cell lines tested under oxic conditions (IC50 >100 μM). Exhibits anti-tumor efficacy in vivo when combined with oxic cell cytotoxins; enhances the anti-tumor effect of cyclophosphamide (Cat. No. 4091) in a mouse tumor model.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
AQ4N: a new approach to hypoxia-activated cancer chemotherapy.
Patterson and McKeown
Br.J.Cancer, 2000;83:1589 -
Effects of cytokine-induced macrophages on the response of tumor cells to banoxantrone (AQ4N).
Mehibel et al.
Mol.Cancer Ther., 2009;8:1261 -
Enhancement of the anti-tumour effect of cyclophosph. by the bioreductive drugs AQ4N and tirapazamine.
Friery et al.
Br.J.Cancer, 2000;82:1469
Product Datasheets
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for Banoxantrone dihydrochloride
There are currently no reviews for this product. Be the first to review Banoxantrone dihydrochloride and earn rewards!
Have you used Banoxantrone dihydrochloride?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
